Two Sigma Investments, LP Trevena Inc Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.16 - $100.0 $6,518 - $4.07 Million
40,738 Added 86.03%
88,092 $13,000
Q2 2022

Aug 15, 2022
SELL
$0.2 - $0.5 $83,594 - $208,985
-417,971 Reduced 89.82%
47,354 $20,000
Q1 2022

May 16, 2022
SELL
$0.41 - $0.63 $128,573 - $197,563
-313,593 Reduced 40.26%
465,325 $256,000
Q4 2021

Feb 14, 2022
BUY
$0.57 - $1.29 $326,686 - $739,344
573,135 Added 278.51%
778,918 $454,000
Q3 2021

Nov 15, 2021
BUY
$1.11 - $1.7 $180,786 - $276,880
162,871 Added 379.55%
205,783 $253,000
Q2 2021

Aug 16, 2021
SELL
$1.46 - $2.25 $1.81 Million - $2.78 Million
-1,237,386 Reduced 96.65%
42,912 $73,000
Q1 2021

May 17, 2021
BUY
$1.77 - $2.93 $1.68 Million - $2.79 Million
951,591 Added 289.5%
1,280,298 $2.29 Million
Q4 2020

Feb 16, 2021
BUY
$2.13 - $3.26 $700,145 - $1.07 Million
328,707 New
328,707 $703,000
Q3 2020

Nov 16, 2020
SELL
$1.53 - $3.13 $252,861 - $517,291
-165,269 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$0.48 - $1.75 $79,329 - $289,220
165,269 New
165,269 $248,000
Q1 2020

May 15, 2020
SELL
$0.56 - $0.97 $21,860 - $37,865
-39,037 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$0.62 - $1.06 $1,498 - $2,562
-2,417 Reduced 5.83%
39,037 $33,000
Q3 2019

Nov 14, 2019
SELL
$0.81 - $1.06 $34,126 - $44,658
-42,131 Reduced 50.4%
41,454 $40,000
Q2 2019

Aug 14, 2019
BUY
$0.94 - $1.6 $78,569 - $133,736
83,585 New
83,585 $86,000
Q1 2019

May 15, 2019
SELL
$0.51 - $1.88 $49,162 - $181,226
-96,397 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$0.39 - $3.47 $99,251 - $883,087
-254,492 Reduced 72.53%
96,397 $41,000
Q3 2018

Nov 14, 2018
SELL
$1.39 - $2.25 $274,726 - $444,701
-197,645 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$1.44 - $2.24 $284,608 - $442,724
197,645 New
197,645 $285,000

About TREVENA INC

TRVN Quotes by TradingView
  • Ticker TRVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 173,680,992
  • Market Cap $273M
  • Description
  • Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...
More about TRVN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email